Articles From: Tethys Petroleum Limited: Board Changes to Tetraphase Pharmaceuticals to Participate in Upcoming Investor Conferences


http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0977076001&sourceType=1 http://www.ccnmatthews.com/logos/20090524-tethylo2.JPG GRAND CAYMAN, CAYMAN ISLANDS --
Sign-up for Tethys Petroleum Limited: Board Changes investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0979602001&sourceType=1 http://www.ccnmatthews.com/logos/20090524-tethylo2.JPG GRAND CAYMAN, CAYMAN ISLANDS --
Sign-up for Tethys Petroleum Limited: Board Changes investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0981711001&sourceType=1 http://www.ccnmatthews.com/logos/20090524-tethylo2.JPG GRAND CAYMAN, CAYMAN ISLANDS --
Sign-up for Tethys Petroleum Limited: Corporate Update investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0986335001&sourceType=1 http://www.ccnmatthews.com/logos/20090524-tethylo2.JPG GRAND CAYMAN, CAYMAN ISLANDS --
Sign-up for Tethys Petroleum Limited: Kazakhstan - Akkulka Exploration Contract Extension investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0987329001&sourceType=1 http://www.ccnmatthews.com/logos/20090524-tethylo2.JPG GRAND CAYMAN, CAYMAN ISLANDS --
Sign-up for Tethys Petroleum Limited: Kazakhstan - Gas Production Doubles investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0976276001&sourceType=1 http://www.ccnmatthews.com/logos/20090524-tethylo2.JPG ALMATY, KAZAKHSTAN --
Sign-up for Tethys Petroleum Limited: Kazakhstan Update - Extension on HanHong Deal investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0981168001&sourceType=1 http://www.ccnmatthews.com/logos/20090524-tethylo2.JPG GRAND CAYMAN, CAYMAN ISLANDS --
Sign-up for Tethys Petroleum Limited: New Executive Chairman and Board Committee Appointments investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0987651001&sourceType=1 http://www.ccnmatthews.com/logos/20090524-tethylo2.JPG GRAND CAYMAN, CAYMAN ISLANDS --
Sign-up for Tethys Petroleum Limited: New US$6 Million Loan Financing investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0976229001&sourceType=1 http://www.ccnmatthews.com/logos/20090524-tethylo2.JPG DUSHANBE, TAJIKISTAN --
Sign-up for Tethys Petroleum Limited: Tajikistan Seismic Programme Commences investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0978864001&sourceType=1 http://www.ccnmatthews.com/logos/20090524-tethylo2.JPG GRAND CAYMAN, CAYMAN ISLANDS --
Sign-up for Tethys Petroleum Limited: Third Quarter 2014 Financial Results and Activity Update investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0977201001&sourceType=1 http://www.ccnmatthews.com/logos/20090524-tethylo2.JPG GRAND CAYMAN, CAYMAN ISLANDS --
Sign-up for Tethys Petroleum Limited: Update on Requisition of Extraordinary General Meeting investment picks
Tetra Tech, Inc. (NASDAQ: TTEK) today announced the planned dates for its fourth quarter 2014 results and conference call.
Sign-up for Tetra Tech Announces Planned Dates for Fourth Quarter 2014 Results and Conference Call investment picks
Tetra Tech, Inc. (NASDAQ: TTEK) today announced results for the fourth quarter and fiscal year ended September 28, 2014.
Sign-up for Tetra Tech Reports Fourth Quarter and Fiscal 2014 Results investment picks
Tetra Tech, Inc. (NASDAQ: TTEK) announced today it has been awarded a $216 million indefinite delivery indefinite quantity contract from the U.S. Agency for International Development (USAID) to support the implementation of USAID’s program, the Promoting Gender Equity in National Priority Programs Project (PROMOTE) in Afghanistan.
Sign-up for Tetra Tech Wins $216 Million USAID Gender Equity Contract investment picks
Tetra Tech, Inc. (NASDAQ: TTEK) announced today it has been awarded a $650 million multiple-award indefinite delivery indefinite quantity (IDIQ) contract by the U.S. Agency for International Development (USAID) to support the improvement of urban infrastructure in developing countries.
Sign-up for Tetra Tech Wins $650 Million USAID Urban Infrastructure Contract investment picks
THE WOODLANDS, Texas , Dec.
Sign-up for TETRA Technologies, Inc. Announces New Senior Vice President investment picks
THE WOODLANDS, Texas , Nov.
Sign-up for TETRA Technologies, Inc. Announces Third Quarter 2014 Results And Updates 2014 Earnings Guidance investment picks
THE WOODLANDS, Texas , Oct.
Sign-up for TETRA Technologies, Inc. Announces Third Quarter 2014 Results Press Release And Conference Call Schedule investment picks
MALVERN, Pa., Nov.
Sign-up for TetraLogic Pharmaceuticals Announces Results of Preclinical Studies in Hepatitis B investment picks
MALVERN, Pa., Nov.
Sign-up for TetraLogic Pharmaceuticals to Host Investor Forum on November 10, 2014 investment picks
MALVERN, Pa., Dec.
Sign-up for TetraLogic Provides Update on Ovarian Cancer Study investment picks
MALVERN, Pa., Dec.
Sign-up for TetraLogic to Participate in Two Conferences in December investment picks
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a clinical stage biopharmaceutical company developing novel antibiotics to treat life-threatening multidrug-resistant (MDR) infections, today announced positive top-line results from IGNITE 1, the Company’s Phase 3 clinical trial of eravacycline for the treatment of complicated intra-abdominal infection (cIAI) compared to ertapenem.
Sign-up for Tetraphase Announces Positive Top-line Results from Phase 3 IGNITE 1 Clinical Trial of Eravacycline in Complicated Intra-abdominal Infections investment picks
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) , a clinical-stage biopharmaceutical company developing novel antibiotics for serious and life-threatening multidrug-resistant (MDR) bacterial infections, today announced that it has been selected for addition to the NASDAQ Biotechnology Index® (Nasdaq:^NBI). The annual re-ranking of the NASDAQ Biotechnology Index will become effective upon market open on Monday, December 22, 2014.
Sign-up for Tetraphase Pharmaceuticals Added to NASDAQ Biotechnology Index investment picks
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today reported financial results and key operating highlights for the third quarter ended September 30, 2014.
Sign-up for Tetraphase Pharmaceuticals Reports Third-Quarter 2014 Financial Results investment picks
Tetraphase Pharmaceuticals, Inc. (NASDAQ: TTPH) , a clinical-stage biopharmaceutical company whose lead product candidate, eravacycline, is being developed as a broad-spectrum intravenous and oral antibiotic designed to be effective against dangerous, drug-resistant bacteria (including multidrug-resistant (MDR) Gram-negative pathogens), today announced its participation in two upcoming investor conferences: A live audio webcast of the Stifel presentation will be available on the Company's website at http://ir.tphase.com/events.cfm .
Sign-up for Tetraphase Pharmaceuticals to Participate in Upcoming Investor Conferences investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Tethys Petroleum Limited: Board Changes to Tetraphase Pharmaceuticals to Participate in Upcoming Investor Conferences
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent